902
Views
35
CrossRef citations to date
0
Altmetric
Review Article

A Critical Review of the Properties of Fusidic Acid and Analytical Methods for Its Determination

&
Pages 352-360 | Published online: 09 Jun 2016

References

  • Adenis, J. P.; Arrata, M.; Gastaud, P.; Limon, S.; Massin, M. A Multicenter Randomized Study of Fusidic Acid Ophthalmic Gel and Rifamycine Eyedrops in Acute Conjunctivitis [in French]. J. Fr. Ophtalmol. 1989, 12, 317–322.
  • Al-Shaalan, N. H. Atomic Absorption Spectrometric Determination of Fusidic Acid in Bulk Powder and in Pharmaceutical Dosage Form. J. Chem. Pharm. Res. 2010, 2, 135–143.
  • Ankam, R.; Mukkanti, K.; Durgaprasad, S.; Naidu, P. V. L. Simultaneous Determination of Halobetasol Propionate and Fusidic Acid Related Substances by Reversed Phase High Performance Liquid Chromatographic Method. Asian J. Chem. 2010, 22, 3376–3380.
  • Bartoshevich, I.; Egorov, A. A.; Gol'dshtein, V. L.; Jones, I. J.; Luni, P. A. Utilization of Automatic Systems for Determining the Biological Activity of Antibiotics by the Agar Diffusion Method. Antibiotiki 1976, 21, 122–127.
  • British Pharmacopoeia; The Stationery Office: London, 2010; Vol. I, pp 155–163, Vol. III, pp 2373–2375.
  • Brodersen, R. Fusidic Acid Binding to Serum Albumin and Interaction with Binding of Bilirubin. Acta Paediatr. Scand. 1985, 74, 874–880.
  • Brown, N. M.; Reeves, D. S.; McMullin, C. M. The Pharmacokinetics and Protein Binding of Fusidic Acid in Patients with Severe Renal Failure Requiring Either Haemodialysis or Continuous Ambulatory Peritoneal Dialysis. J. Antimicrob. Chemother. 1997, 39, 803–809.
  • Byrne, J.; Velasco-Torrijos, T.; Reinhardt, R. Development and Validation of a Novel Stability-Indicating HPLC Method for the Simultaneous Assay of Betamethasone-17-Valerate, Fusidic Acid, Potassium Sorbate, Methylparaben and Propylparaben in a Topical Cream Preparation. J. Pharm. Biomed. Anal. 2014, 96, 111–117.
  • Byrne, J; Velasco-Torrijos, T.; Reinhardt, R. An RP-HPLC Method for the Stability-Indicating Analysis of Impurities of Both Fusidic Acid and Betamethasone-17-Valerate in a Semi-Solid Pharmaceutical Dosage Form. J. Chromatogr. Sci. 2015, 53, 1498–1503.
  • Carlstrom, A.; Dornbusch, K.; Hagelberg, A. Use of Electrophoresis in the Identification and Quantitation of Antibiotics Administered in Combinations. Scand. J. Infect. Dis. 1977, 9, 46–54.
  • Chater, E. H.; Flynn, J.; Wilson, A. L. Fucidin Levels in Osteomyelitis. J. Ir. Med. Assoc. 1972, 65, 506–508.
  • Chen, N.; Wang, Y.; Chen, M. Determination of Fusidic Acid Ophthalmic Emulsion by HPLC. China Med. Herald 2009, 22, 72–73.
  • Chen, H. J.; Hung, W. C.; Tseng, S. P.; Tsai, J. C.; Hsueh, P. R.; Teng, L. J. Fusidic Acid Resistance Determinants in Staphylococcus aureus Clinical Isolates. Antimicrob. Agents Chemother. 2010, 54, 4985–4991.
  • Christiansen, K. Fusidic Acid Adverse Drug Reactions. Int. J. Antimicrob. Agents 1999, 12, S3–S9.
  • Cole, R. J.; Schweikert, M. A. Handbook of Secondary Fungal Metabolites; Academic Press: New York, 2003; Vol. 1, p 492.
  • Collignon, P.; Turnidge, J. Fusidic Acid in Vitro Activity. Int. J. Antimicrob. Agents 1999, 12, S45–S58.
  • Corrêa, J. C. R.; D'Arcy, D. M.; Serra, C. H. R.; Salgado, H. R. N. A Critical Review of Properties of Darunavir and Analytical Methods for Its Determination. Crit. Rev. Anal. Chem. 2014, 44, 16–22.
  • Costi, E. M.; Sicilia, M. D.; Rubio, S.; Pérez-Bendito, D. Quantitation of Fusidane Antibiotics in Pharmaceuticals Using tSurfactant–Dye Binding Degree Method. Anal. Chim. Acta 2005, 549, 159–165.
  • Cundliffe, E. The Mode of Action of Fusidic Acid. Biochem. Biophys. Res. Commun. 1972, 46, 1794–1801.
  • Darley, E. S.; MacGowan, A. P. Antibiotic Treatment of Gram-Positive Bone and Joint Infections. J. Antimicrob. Chemother. 2004, 53, 928–935.
  • Davis, J. S. Management of Bone and Joint Infections Due to Staphylococcus aureus. Int. Med. J. 2005, 35, S79–S96.
  • Deodhar, S. D.; Russell, F.; Dick, W. C.; Nuki, G.; Buchanan, W. W. Penetration of Sodium Fusidate (Fusidin) in the Synovial Cavity. Scand J. Rheumatol. 1972, 1, 33–39.
  • Diassi, P. A.; Krakower, G. W.; Bacso, I.; Ann Van Dine, H. Transformations of Fusidic Acid—I: Oxygenated-4α;,8,14-trimethyl-18-norandrostanes. Tetrahedron 1966, 22, 3443–3458.
  • Duvold, T.; Sorensen, M. D.; Bjoerkling, F.; Henriksen, A. S.; Rastrup-Andersen, N. Synthesis and Conformational Analysis of Fusidic Acid Side Chain Derivatives in Relation to Antibacterial Activity. J. Med. Chem. 2001, 44, 3125–3131.
  • European Pharmacopoeia, 7th ed.; Council of Europe: 2010; Vol. 2, pp 1393–1399.
  • Evans, D. I. Granulocytopenia Due to Fusidic Acid. Lancet 1988, 2, 851.
  • Fernandes, P.; Pereira, D. Efforts to Support the Development of Fusidic Acid in the United States. Clin. Infect. Dis. 2011, 52, S542–S546.
  • Fiorentino, F. A. M.; Corrêa, M. A.; Salgado, H. R. N. Analytical Methods for the Determination of Chlorhexidine: A Review. Crit. Rev. Anal. Chem. 2010, 40, 89–101.
  • George, A.; Rubin, G. A Systematic Review and Meta-analysis of Treatments for Impetigo. Br. J. Gen. Pract. 2003, 53, 480–487.
  • Gilchrist, S. E.; Letchford, K.; Burt, H. M. The Solid-State Characterization of Fusidic Acid. Int. J. Pharm. 2012, 422, 245–253.
  • Giordano-Labadie, F.; Pelletier, N.; Bazex, J. Contact Dermatitis from Fusidic Acid. Contact Dermatitis 1996, 34, 159.
  • Godtfredsen, W. O.; Vangedal, S. The Structure of Fusidic Acid. Tetrahedron 1962, 18, 1029–1048.
  • Godtfredsen, W. O.; Jahnsen, S.; Lorck, H.; Roholt, K.; Tybring, L. Fusidic Acid, a New Antibiotic. Nature 1962, 193, 987.
  • Godtfredsen, W. O.; Von Daehne, W.; Vangedal, S. The Stereochemistry of Fusidic Acid. Tetrahedron 1965, 21, 350–353.
  • Godtfredsen, W. O.; Von Daehne, W.; Tybring, L.; Vangedal, S. Fusidic Acid Derivatives. I. Relation between Structure and Antibacterial Activity. J. Med. Chem. 1966, 9, 15–22.
  • Godtfredsen, W. O.; Rastrup-Andersen, N.; Vangedal, S.; Ollis, W. D. Metabolites of Fusidium coccineum. Tetrahedron 1979, 35, 2419–2431.
  • Golledge, C. Fusidic Acid in Other Infections. Int. J. Antimicrob. Agents 1999, 12, S11–S15.
  • Gontijo, B.; Pereira, L. B.; Silva, C. M. R. Antibióticos em dermatologia; Sociedade de Brasileira de Pediatria: Rio de Janeiro, Brazil, 2003; Módulo B, Fascículo XIII.
  • Goswami, N.; Gupta, V. R. M.; Jogia, A. H. Development and Validation of a Novel Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Halometasone, Fusidic Acid, Methylparaben, and Propylparaben in Topical Pharmaceutical Formulation. Sci. Pharm. 2013, 81, 505–518.
  • Guenthner, S. H.; Wenzel, R. P. In Vitro Activities of Teichomycin, Fusidic Acid, Flucloxacillin, Fosfomycin, and Vancomycin against Methicillin Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 1984, 26, 268–269.
  • Hassan, S. M.; Amer, S. M.; Amer, M. M. Determination of Fusidic Acid and Sodium Fusidate in Pharmaceutical Dosage Forms by First-Derivative Ultraviolet Spectrophotometry. Analyst 1987, 112, 1459–1461.
  • Hierholzer, G.; Knothe, H.; Rehn, J. Penetration of Fusidic Acid into Aseptic Bone Tissue. Arzneimittelforschung 1970, 20, 1473–1476.
  • Hikal, A. H. Assay of Fusidic Acid in Plasma By High-Performance Liquid Chromatography. Int. J. Pharm. 1983, 13, 297–301.
  • Hikal, A. H.; Shibl, A.; El-Hoofy, S. Determinations of Sodium Fusidate and Fusidic Acid in Dosage Forms by High-Performance Liquid Chromatography and a Microbiological Method. J. Pharm. Sci. 1982, 71, 1297–1298.
  • Hogan, D. J. Widespread Dermatitis after Topical Treatment of Chronic Leg Ulcers and Stasis Dermatitis. Can. Med. Assoc. J. 1988, 138, 336–338.
  • Hong, C.; Rong, Z. Determination of Dexamethasone Acetate and Fusidic Acid in Compound Dexamethasone and Fusidic Acid Cream. Zhongguo Kangshengsu Zazhi 2012, 37, 924–926.
  • Humble, M. W.; Eykyn, S.; Phillips, I. Staphylococcal Bacteraemia, Fusidic Acid, and Jaundice. Br. Med. J. 1980, 280, 1495–1498.
  • Iwarson, S.; Fasth, S.; Olaison, L.; Hulten, L. Adverse Reactions to Intravenous Administration of Fusidic Acid. Scand. J. Infect. Dis. 1981, 13, 65–67.
  • Jones, R. N.; Mendes, R. E.; Sader, H. S.; Castanheira, M. In Vitro Antimicrobial Findings for Fusidic Acid Tested against Contemporary (2008–2009) Gram-Positive Organisms Collected in the United States. Clin. Infect. Dis. 2011, 52, S477–S486.
  • Kanazawa, Y.; Kuramata, T. Fusidic Acid. Assay for Microbiologically Active Concentration in Body Fluids and Sensitivity Test by Agar Diffusion [in Japanese]. J. Antibiot. B 1964, 17, 7–11.
  • Klyuev, N. A., Suchkova, G. S.; Lokshin, G. B.; Kuzovkov, A. D. Dissociative Ionization of Fusidic Acid and the Products of Its Thermolysis in the Temperature Range of 30-250°C. Chem. Nat. Compd. 1980, 17, 183–188.
  • Koroleva, V. G. Agar-Diffusion Method for Determination of Fusidin in Body Fluids and Tissues. Antibiotiki 1971, 16, 727–729.
  • Korolkovas, A. Dicionário Terapêutico Guanabara, 17th ed.; Guanabara Koogan: Rio de Janeiro, Brazil, 2010; p 105.
  • Krzek, J.; Hubicka, U.; Szczepańczyk, J.; Kwiecień, A.; Rzeszutko, W. Simultaneous Determination of Fusidic Acid, m- and p-Hydroxybenzoates and Butylhydroxyanisole by TLC with Densitometric Detection in UV. J. Liq. Chrom. Relat. Technol. 2006, 29, 2129–2139.
  • Leibowitz, G.; Golan, D.; Yeshurun, D.; Brezis, M. Leukopenia and Thrombocytopenia Due to Fusidic Acid. Postgrad. Med. J. 1991, 67, 591–592.
  • Long, B. H. Fusidic Acid in Skin and Soft-Tissue Infections. Acta Dermatol. Venereol. 2008, 216, 14–20.
  • Lopes, C. C. G. O.; Salgado, H. R. N. Development and Validation of a Stability-Indicative Agar Diffusion Assay to Determine the Potency of Linezolid in Tablets in the Presence of Photodegradation Products. Talanta 2010, 82, 918–922.
  • Luque, J. I. P. Antimicrobianos tópicos en Dermatología. Actas Dermosifiliogr. 2007, 98, 29–39.
  • Matthews, P. C.; Berendt, A. R.; McNally, M. A.; Byren, I. Diagnosis and Management of Prosthetic Joint Infection. Br. Med. J. 2009, 338, 1773.
  • Mazumder, R. Sites of Action of Fusidic Acid in Eukaryotes: Inhibition by Fusidic Acid of a Ribosome-Independent GTPase from Artemia salina Embryos. Eur. J. Biochem. 1975, 58, 549–554.
  • Moreno, A. H.; Salgado, H. R. N. Microbiological Assay for Ceftazidime Injection. J. AOAC Int. 2007, 90, 1379–1382.
  • Morgan, J.; Joyce-Menekse, M. E.; Rowlands, R. T.; Gilbert, I. H.; Lloyd, D. Rapid and Sensitive Quantitation of Antibiotics in Fermentations by Electrospray Mass Spectrometry. Rapid. Commun. Mass. Spectrom. 2001, 15, 1229–1238.
  • Nawaz, M.; Arayne, M. S.; Sultana, N.; Haider, A.; Hisaindee, S. Simultaneous Determination of Fusidic Acid and Steroids from Bulk Drugs and Human Plasma by Reversed Phase HPLC. Acta Chromatogr. 2014, 26, 57–66.
  • O'Neil, M. J., ed. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 14th ed.; Merck: Whitehouse Station, NJ, 2006; p 4318.
  • Patrick, G. L. An Introduction to Medicinal Chemistry, 4th ed.; Oxford University Press: New York, 2009; p. 752.
  • Pedroso, T. M.; Salgado, H. R. N. Development and Validation of a Microbiological Assay by Turbidimetry to Determine the Potency of Cefazolin Sodium in the Lyophilized Powder Form. Anal. Methods 2014, 6, 1391–1396.
  • Peh, K.-K.; Tan, Y. T. Simple High-Performance Liquid Chromatographic Method for Simultaneous Determination of Fusidic Acid and Betamethasone Dipropionate in a Cream Formulation. Int. J. Pharm. Compd. 2000, 4, 229–231.
  • Perry, M. J.; Hendricks-Gittins, A.; Stacey, L. M.; Adlard, M. W.; Noble, W. C. Fusidane Antibiotics Produced by Dermatophytes. J. Antibiot. 1983, 36, 1659–1663.
  • Pfaller, M. A.; Castanheira, M.; Sader, H. S.; Jones, R. N. Evaluation of the Activity of Fusidic Acid Tested against Contemporary Gram-Positive Clinical Isolates from the USA and Canada. Int. J. Antimicrob. Agents 2010, 35, 282–287.
  • Rahman, A.; Hoffman, N. E. High-Performance Liquid Chromatographic Determination of Fusidic Acid in Plasma. J. Chromatogr. B 1988, 433, 159–166.
  • Rang, H. P.; Dale, M. M.; Ritter, J. M.; Flower, R. J. Farmacologia, 6th ed.; Elsevier: Rio de Janeiro, Brazil, 2008; p 829.
  • Revell, P.; Nicholson, F.; Pearson, T. C. Granulocytopenia Due to Fusidic Acid. Lancet 1988, 2, 454–455.
  • Ribani, M.; Bottoli, C. B. G.; Collins, C. H.; Jardim, I. C. S. F.; Melo, L. F.C. Validação em métodos cromatográficos e eletroforéticos. Quim. Nova 2004, 27, 771–780.
  • Romaguera, C.; Grimalt, F. Contact Dermatitis to Fusidic Acid. Contact Dermatitis 1985, 12, 176–177.
  • Satarova, D. E.; Korchagin, V. B.; Stepushkina, V. V.; Makarova, R. A. Spectrophotometric Method for Determination of Fusidic Acid. Antibiot. Khimioter. 1989, 34, 566–569.
  • Sattar, M. A.; Barrett, S. P.; Cawley, M. I. D. Concentrations of Some Antibiotics in Synovial Fluid after Oral Administration, with Special Reference to Antistaphylococcal Acitivity. Ann. Rheum. Dis. 1983, 42, 67–74.
  • Sewell, G. J.; Palmer, A. The Chemical and Physical Stability of Three Intravenous Infusions Subjected to Frozen Storage and Microwave Thawing. Int. J. Pharm. 1991, 72, 57–63.
  • Shaikh, S.; Muneera, M. S.; Thusleem, O. A.; Tahir, M.; Kondaguli, A. V. A Simple RP-HPLC Method for the Simultaneous Quantitation of Chlorocresol, Mometasonefuroate, and Fusidic Acid in Creams. J. Chromatogr. Sci. 2009, 47, 178–183.
  • Silva, L. M.; Salgado, H. R. N. Rapid Turbidimetric Assay to Potency Evaluation of Tigecycline in Lyophilized Powder. J. Microbiol. Methods 2015, 110, 49–53.
  • Silva, N. N.; Chaher, J. A.; Bernhard, A. Fusidic Acid against Staphylococcus aureus. Rev. Bras. Med. 1965, 22, 126.
  • Smeenk, G.; Sebens, F. W.; Houwing, R. H. Use and Adverse Reactions of Local Antibiotics and Disinfectants on the Skin. Ned. Tijdschr. Geneeskd. 1999, 143, 1140–1143.
  • Sorense, N. H. Liquid Chromatographic Determination of Fusidic Acid in Serum. J. Chromatogr. B 1988, 430, 400–405.
  • Sorense, B.; Sejrsen, P.; Thomsen, M. Fusidin, Pro-Staphylin, and Penicillin Concentrations in Burn Crusts. Acta Chir. Scand. 1966, 131, 423–429.
  • Spelman, D. Fusidic Acid in Skin and Soft Tissue Infections. Int. J. Antimicrob. Agents 1999, 12, S59–S66.
  • Stüttgen, G.; Bauer, E. Penetration and Permeation into Human Skin of Fusidic Acid in Different Galenical Formulation. Arzneimittelforschung 1988, 38, 730–735.
  • Tanaka, N.; Kinoshita, T.; Masukawa, H. Mechanism of Protein Synthesis Inhibition by Fusidic Acid and Related Antibiotics. Biochem. Biophys. Res. Commun. 1968, 15, 278–283.
  • Tavares, W. Manual de Antibióticos e Quimioterápicos Antiinfecciosos; Atheneu: São Paulo, Brazil, 1999; p 792.
  • Toh, S. M.; Xiong, L.; Arias, C. A.; Villegas, M. V.; Lolans, K.; Quinn, J.; Mankin, A. S. Acquisition of a Natural Resistance Gene Renders a Clinical Strain of Methicillin-Resistant Staphylococcus aureus Resistant to the Synthetic Antibiotic Linezolid. Mol. Microbiol. 2007, 64, 1506–1514.
  • Tótoli, E. G.; Salgado, H. R.N. Development and Validation of a Rapid Turbidimetric Assay to Determine the Potency of Ampicillin Sodium in Powder for Solution for Injection Anal. Methods 2013, 5, 5923–5928.
  • Trampuz, A.; Zimmerli, W. Prosthetic Joint Infections: Update in Diagnosis and Treatment. Swiss Med. Wkly. 2005, 135, 243–251.
  • Turnidge, J. Fusidic Acid Pharmacology, Pharmacokinetics and Pharmacodynamics. Int. J. Antimicrob. Agents 1999, 12, S23–S34.
  • Verbist, L. The Antimicrobial Activity of Fusidic Acid. J. Antimicrob. Chemother. 1990, 25, 1–5.
  • Vieira, D.; Fiuza, T.; Salgado, H. R. N. Development and Validation of a Rapid Turbidimetric Assay to Determine the Potency of Cefuroxime Sodium in Powder for Dissolution for Injection. Pathogens 2014, 3, 656–666.
  • Vladimirov, S.; Fiser, Z.; Agbaba, D.; Zivanov-Stakic, D. Spectrophotometric Determination of Fusidic Acid and Sodium Fusidate in Dosage Forms. J. Pharm. Biomed. Anal. 1995, 13, 675–678.
  • Walsh, C. Antibiotics: Actions, Origins, Resistance; ASM Press: Washington, DC, 2003; p 335.
  • Webb, J.; Wilson, H. G.; Rao, A. Staphylococcal Endocarditis Treated by Intravenous Administration of Fusidic Acid and Penicillin. Med. J. Aust. 1968, 1, 131–133.
  • Wilkinson, J. D. Fusidic Acid in Dermatology. Brit. J. Dermatol. 1998, 139, 37–40.
  • Yang, S. J.; Nast, C. C.; Mishra, N. N.; Yeaman, M. R.; Fey, P. D.; Bayer, A. S. Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus: Evidence for Multiple Resistance Mechanisms. Antimicrob. Agents Chemother. 2010, 54, 3079–3085.
  • Zhao, M.; Gödecke, T.; Gunn, J.; Duan, J. A.; Che, C. T. Protostane and Fusidane Triterpenes: A Mini-Review. Molecules 2013, 18, 4054–4080.
  • Zimmerli, W.; Trampuz, A.; Ochsner, P. E. N. Prosthetic-Joint Infections. N. Engl. J. Med. 2004, 351, 1645–1654.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.